日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Examination of HER3 targeting in cancer using monoclonal antibodies

利用单克隆抗体研究HER3靶向治疗癌症

Gaborit, Nadège; Abdul-Hai, Ali; Mancini, Maicol; Lindzen, Moshit; Lavi, Sara; Leitner, Orith; Mounier, Lucile; Chentouf, Myriam; Dunoyer, Sai; Ghosh, Manjusha; Larbouret, Christel; Chardès, Thierry; Bazin, Hervé; Pèlegrin, André; Sela, Michael; Yarden, Yosef

Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression

Navigator-3 是一种细胞迁移调节因子,可能抑制乳腺癌的进展。

Cohen-Dvashi, Hadas; Ben-Chetrit, Nir; Russell, Roslin; Carvalho, Silvia; Lauriola, Mattia; Nisani, Sophia; Mancini, Maicol; Nataraj, Nishanth; Kedmi, Merav; Roth, Lee; Köstler, Wolfgang; Zeisel, Amit; Yitzhaky, Assif; Zylberg, Jacques; Tarcic, Gabi; Eilam, Raya; Wigelman, Yoav; Will, Rainer; Lavi, Sara; Porat, Ziv; Wiemann, Stefan; Ricardo, Sara; Schmitt, Fernando; Caldas, Carlos; Yarden, Yosef

Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties

接受干扰素-β 治疗的多发性硬化症患者补充维生素 D:一项评估对流感样症状和免疫调节特性影响的随机对照试验

Daniel Golan, Basheer Halhal, Lea Glass-Marmor, Elsebeth Staun-Ram, Orit Rozenberg, Idit Lavi, Sara Dishon, Mira Barak, Sophia Ish-Shalom, Ariel Miller

Protein phosphatase magnesium dependent 1A (PPM1A) plays a role in the differentiation and survival processes of nerve cells.

蛋白磷酸酶镁依赖性1A(PPM1A)在神经细胞的分化和存活过程中发挥作用

Shohat Meytal, Ben-Meir Daniella, Lavi Sara

Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands

利用化疗药物和针对EGF受体配体的抗体混合物进行个体化癌症免疫疗法

Lindzen, Moshit; Lavi, Sara; Leitner, Orith; Yarden, Yosef

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis

利用单克隆抗体组合持续清除ErbB-2/HER2过表达肿瘤:受体内吞作用的相关性

Ben-Kasus, Tsipi; Schechter, Bilha; Lavi, Sara; Yarden, Yosef; Sela, Michael

Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy

单克隆抗体联合应用对受体酪氨酸激酶的协同下调作用:对癌症免疫疗法的启示

Friedman, Lilach M; Rinon, Ariel; Schechter, Bilha; Lyass, Ljuba; Lavi, Sara; Bacus, Sarah S; Sela, Michael; Yarden, Yosef